Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

12.20 +0.03 (+0.26%)
Delayed Quote Updated: 2:58 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript ↗
Medtech segment surges 13.2% as NanoKnife prostate procedures hit record volumes. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Why AngioDynamics Crashed Today ↗
AngioDynamics beats earnings, and drops 20%. 
Via The Motley Fool
Traders are paying attention to the gapping stocks in Thursday's session. ↗
Via Chartmill
AngioDynamics (NASDAQ:ANGO) Posts Narrower Q1 Loss, Holds Guidance Below Consensus ↗
Via Chartmill
AngioDynamics (NASDAQ:ANGO) Surges on Strong Quarterly Beat as Med Tech Segment Drives Growth ↗
Via Chartmill
AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance ↗
Via Chartmill
AngioDynamics Inc. (NASDAQ:ANGO) Reports Narrowed Loss and Revenue Beat in Q2 ↗
Via Chartmill
News headline image
AngioDynamics Q1 Earnings Call Highlights ↗
AngioDynamics (NASDAQ:ANGO) reported fiscal 2027 first-quarter revenue growth of 6.9% to $80.9 million, led by continued expansion in its Med Tech segment, while the company maintained its full-year... 
Via MarketBeat
Topics Earnings
News headline image
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027 ↗
AngioDynamics (NASDAQ:ANGO) expects its MedTech business to become the majority of company revenue in fiscal 2027, as the company continues a multiyear shift away from slower-growth legacy markets and... 
Via MarketBeat
News headline image
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript ↗
Med Tech revenue surged 16.7% as company shifts toward higher-margin products. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
AngioDynamics Q4 Earnings Call Highlights ↗
AngioDynamics (NASDAQ:ANGO) reported higher fiscal fourth-quarter and full-year revenue, driven by continued growth in its med tech portfolio, while management said the company remains focused on... 
Via MarketBeat
Topics Earnings
News headline image
Full Transcript: AngioDynamics Q4 2026 Earnings Call ↗
AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
News headline image
Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability
The medical technology sector has long been a bellwether for the health of the broader economy and the efficiency of the healthcare system. Today, April 2, 2026, AngioDynamics (NASDAQ:ANGO) provided... 
Via MarketMinute
Topics Economy Retirement
News headline image
Bastion Bets on Government Spending with $8 Million New Stake in Parsons ↗
Parsons delivers technology-driven solutions for defense, intelligence, and critical infrastructure clients across North America and beyond. 
Via The Motley Fool
News headline image
AngioDynamics (ANGO) Q1 2026 Earnings Transcript ↗
AngioDynamics (ANGO) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
AngioDynamics (ANGO) Q3 2025 Earnings Transcript ↗
AngioDynamics (ANGO) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
AngioDynamics (ANGO) Q1 2025 Earnings Transcript ↗
AngioDynamics (ANGO) Q1 2025 Earnings Transcript 
Via The Motley Fool
Topics Economy
News headline image
AngioDynamics (ANGO) Q2 2026 Earnings Transcript ↗
AngioDynamics (ANGO) Q2 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Why AngioDynamics Stock Is Sinking Today ↗
An unexpected departure at the top is overshadowing a positive quarterly update for AngioDynamics. 
Via The Motley Fool
Topics Retirement
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million ↗
Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank? ↗
Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank? 
Via The Motley Fool
News headline image
AngioDynamics Eyes Growth Despite Tariffs ↗
AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected. 
Via Benzinga
News headline image
Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Why Did AngioDynamics Stock Pop Today? ↗
Even 37 years after its founding, AngioDynamics still can't earn a profit. 
Via The Motley Fool
News headline image
What's Fueling The Momentum In AngioDynamics Stock? ↗
Shares of AngioDynamics, Inc. (NASDAQ: ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter. 
Via Benzinga
News headline image
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results ↗
 
Via Benzinga
News headline image
AngioDynamics Inc (NASDAQ:ANGO) Surpasses Q1 Earnings Estimates and Raises Fiscal 2026 Outlook ↗
AngioDynamics (ANGO) beat Q1 FY2026 earnings and revenue estimates, driven by strong Med Tech growth. The company also raised its full-year financial outlook. 
Via Chartmill
News headline image
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus ↗
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed. 
Via Benzinga
Topics Stocks
News headline image
S&P 500 Closes At Record High: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗
CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with record S&P 500 level. 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.